Document is current
Any future updates will be listed below
-
Authors
Webb, Lauren M https://orcid.org/0000-0002-1903-7570
Lundie, Rachel J
Borger, Jessica G
Brown, Sheila L
Connor, Lisa M
Cartwright, Adam NR
Dougall, Annette M
Wilbers, Ruud HP
Cook, Peter C
Jackson‐Jones, Lucy H
Phythian‐Adams, Alexander T https://orcid.org/0000-0003-0426-6562
Johansson, Cecilia
Davis, Daniel M
Dewals, Benjamin G
Ronchese, Franca https://orcid.org/0000-0001-5835-8230
MacDonald, Andrew S
-
Funding
Funding for this research was provided by:
Wellcome Trust (WT086628MA)
Belgian National Fund for Scientific Research Fonds De La Recherche Scientifique ‐ FNRS (CDRJ.0068.17)
RCUK | Medical Research Council (G0701437)
RCUK | Medical Research Council (G0800311)
Manatu Hauora | Health Research Council of New Zealand (HRC14/1003)
National Health and Medical Research Council of Australia (GNT0567069)
- License Information
-
More Information
Article History
Received: 26 July 2016
Revised: 8 March 2017
Accepted: 16 May 2017
First Online: 17 July 2017
Conflict of interest
: F.R., A.S.M., and L.M.C. are listed as inventors on a provisional patent application concerned with the subject matter of this paper. The MCCIR is a joint venture between the University of Manchester, GSK, and AstraZeneca.
